Skip to main content
Log in

No effects of levamisole on cytotoxic drug-induced changes of human granulopoiesis

Die Wirkungslosigkeit von Laevamisol auf zytotoxische, durch Arzneimittel induzierte Veränderungen der menschlichen Granulopoese

  • Original Works
  • Published:
Blut Aims and scope Submit manuscript

Zusammenfassung

Die Wirkung von Laevamisol auf die menschliche Granulopoese wurde bei Patientinnen untersucht, die nach operativer Behandlung eines primären Mammakarzinoms adjuvant chemotherapiert und bei denen ein Teil zusätzlich mit Laevamisol als einem unspezifischen Immunstimulans behandelt wurden. Die Reaktion der Granulopoese auf die zytostatische Therapie,- Veränderungen des peripheren Granulozytenpools, der funktionellen Granulozytenreserve des Markes, der Knochenmarkszytologie und der granulopoetischen Stammzellen (CFU-C) in Mark und peripherem Blut, — wurden durch die Gabe von Laevamisol nicht beeinflu\t. Diese Untersuchungen stehen mit der Vorstellung im Einklang, da\ Laevamisol keine direkte Schädigung der Granulopoese verursacht, sondern da\ ein allergischer Mechanismus der Laevamisol-Agranulocytose zugrunde liegt. Eine günstige Wirkung durch Stimulation der Granulopoese, wie sie für BCG und Corynebacterium parvum angenommen wurde, konnte für Laevamisol unter den Bedingungen dieser Studie nicht gefunden werden.

Summary

The effect of Levamisole on the human granulopoiesis was studied in patients randomized to receive, in addition to adjuvant chemotherapy for primary breast cancer, either no other treatment or additional unspecific immune therapy with Levamisole. The reaction of granulopoiesis to the cytostatic drugs, as characterized by changes of peripheral blood polymorphonuclear neutrophils (PMN), functional bone marrow granulocyte reserve, serial bone marrow cytology, and granulopoietic stem cells (CFU-C) in marrow and blood, was not affected by administration of Levamisole. The data support the concept that Levamisole has no direct effect on human bone marrow granulopoiesis, but that an allergic mechanism is involved in the pathogenesis of Levamisole-induced agranulocytosis. The expectation that Levamisole exerts a beneficial effect by stimulation of the granulopoiesis, as previously suggested for BCG and Corynebacterium parvum, could not be substantiated in our studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Clara, R., Germanes, L: Levamisole and agranulocytosis (Letter to the Editor). LancetI, 47 (1977)

    Google Scholar 

  2. Dale, D. C., Fauci, A. S., Guerry, D., Wolff, S. M.: Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, Prednisone, endotoxin, and etiocholanolone. J. Clin. Invest.56, 808 (1975)

    Google Scholar 

  3. Fisher, B., Wolmark, N.: Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity. Cancer Res.36, 2241 (1976)

    Google Scholar 

  4. Foster, R. S.: Altered toxicity of 5-fluorouracil following treatment with corynebacterium parvum. Cancer Res.38, 850 (1978)

    Google Scholar 

  5. Graze, P.R.: Immunochemotherapy of metastatic breast cancer. In: Systemic therapy for metastatic breast cancer. Haskell, C. M., Sparks, F.C., Graze, P.R., Korenmann, S.G. (eds.) Ann. Int. Med.86, 68 (1977)

  6. Immich, H.: Medizinische Statistik. Stuttgart: Schattauer Verlag 1977

    Google Scholar 

  7. Ladisch, S., Poplack, D.G., Bull, J.M.: Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Guérin. Cancer Res.38, 1049 (1978)

    Google Scholar 

  8. Lohrmann, H.-P., Hansi, W., Heimpel, H.: Human-placenta-conditioned medium for stimulation of human granulopoietic precursor cell (CFU-C) growth in vitro. Blut36, 81 (1978)

    Google Scholar 

  9. Lohrmann, H.-P., Schreml, W., Lang, M., Betzler, M., Fliedner, T.M., Heimpel, H.: Changes of granulopoiesis during and after adjuvant chemotherapy of breast cancer. Br. J. Haematol. (in press) (1978)

  10. Parkinson, D.R., Jerry, L.M., Shibata, H.R., Lewis, M.G., Cano, P.O., Capek, A., Mansell, P.W., Marquis, G.: Complications of cancer immunotherapy with Levamisole. LancetI, 1129 (1977)

    Google Scholar 

  11. Rojas, A.F., Mickiewiez, E., Feierstein, J.N., Glait, H., Olivari, A.J.: Levamisole in advanced human breast cancer. LancetI, 211 (1976)

    Google Scholar 

  12. Symoens, J., Rosenthal, M.J.: Levamisole in the modulation of the immune response: The current experimental and clinical state. J. Reticuloendothel. Soc.21, 175 (1977)

    Google Scholar 

  13. Vanholder, R., Van Hove, W.: Recurrent agranulocytosis after Levamisole (Letter to the Editor). LancetI, 100 (1977)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the Deutsche Forschungsgemeinschaft (SFB 112, Projekt A6)

Levamisole was kindly supplied by Janssen GmbH, Dtisseldorf

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schreml, W., Lohrmann, H.P. No effects of levamisole on cytotoxic drug-induced changes of human granulopoiesis. Blut 38, 331–336 (1979). https://doi.org/10.1007/BF01008147

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01008147

Schlüsselwörter

Key words

Navigation